Recorlev Also Helps to Treat Diabetes in Cushing’s Syndrome, Trial Data Show

Recorlev Also Helps to Treat Diabetes in Cushing’s Syndrome, Trial Data Show

291528

Recorlev Also Helps to Treat Diabetes in Cushing’s Syndrome, Trial Data Show

Recorlev (levoketoconazole), Strongbridge Biopharma’s oral investigational therapy for endogenous Cushing’s syndrome, led to sustained improvements in cortisol and in blood sugar control among patients with both Cushing’s and diabetes, a subgroup analysis of Phase 3 SONICS trial data showed. “Diabetes mellitus [type 1 diabetes] is among the more common complications related to excess levels of cortisol in people with Cushing’s syndrome,” Fredric Cohen, MD, Strongbridge’s chief medical officer, said in a press release. “The SONICS study…

You must be logged in to read/download the full post.